3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Solid Tumors Harboring NTRK Fusion
1
Recurrence
1
Papillomavirus Infections
1
Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Insulin-Like Growth Factor I, Resistance To
1
Gliosarcoma
1
Glioblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms, Male
1
Brain Neoplasms
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
35
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
23
Papillomavirus Vaccines
14
Data Collection
7
Blood Specimen Collection
7
Vaccines
6
Vaccines, Synthetic
5
Educational Status
5
Radiotherapy, Intensity-Modulated
4
Human Papillomavirus Recombinant Vaccine nonavalent
4
Early Intervention, Educational
4
Vaginal Smears
3
Surveys and Questionnaires
3
Polymerase Chain Reaction
3
Paclitaxel
3
Methods
3
Engerix-B
3
Colposcopy
3
Cisplatin
3
halofantrine
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Watchful Waiting
2
Taxes
2
Patient Navigation
2
Papanicolaou Test
2
Observation
2
Light Coagulation
2
Imiquimod
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Papillomavirus Infections
×
Receptor Protein-Tyrosine Kinases
×
Clear all
NCT01588301
2014-09-12
APACHE-2
University Hospital, Tours
Phase EARLY_PHASE1
Completed
5,998 enrolled